Various experiments have indicated the presence in whole human serum of three major thyroxine (T4)-binding 1 proteins: T4-binding globulin (TBG), T4-binding prealbumin (TBPA), and albumin (1, 2). It is well established that, in vitro, TBG and TBPA are the major T4-binding proteins, whereas albumin is a relatively weak secondary carrier (3-5). These proteins interact with the hormone in a reversible binding equilibrium in which the majority of the hormone is bound but a measurable proportion is unbound or free. Free T4 has been suggested as the metabolically active component available to the cells in vivo for degradation, excretion, and initiation of hormonal action, with the bound hormone acting as a metabolically inert reservoir (3-5).
Various experiments have indicated the presence in whole human serum of three major thyroxine (T4)-binding 1 proteins: T4-binding globulin (TBG), T4-binding prealbumin (TBPA), and albumin (1, 2) . It is well established that, in vitro, TBG and TBPA are the major T4-binding proteins, whereas albumin is a relatively weak secondary carrier (3) (4) (5) . These proteins interact with the hormone in a reversible binding equilibrium in which the majority of the hormone is bound but a measurable proportion is unbound or free. Free T4 has been suggested as the metabolically active component available to the cells in vivo for degradation, excretion, and initiation of hormonal action, with the bound hormone acting as a metabolically inert reservoir (3) (4) (5) .
The role of TBG in the transport and peripheral metabolism of T4 in man is well accepted. This acceptance is based on studies demonstrating a consistent relationship between changes in the T4-binding activity of TBG, as assessed by electrophoresis in vitro and changes in the concentration and fractional turnover of T4 in vivo (6) (7) (8) . From these observations, the conclusion has been drawn that TBG regulates the peripheral metabolism of T4 by limiting the concentration of unbound hormone.
The existence of TBPA as a normal constituent of human serum has been satisfactorily demonstrated by several techniques, and earlier doubts concerning its function in binding T4 at physiological pH have been dispelled (5, 9, 10) . The role, if any, of -TBPA in regulating the peripheral metabolism of T4 in vivo has remained uncertain.
As in the case of TBG, attempts have been made to correlate changes in the T4-binding activity of TBPA in vitro with changes in the volume of distribution and fractional turnover of hormone in vivo. Thus, certain abnormal states, such as fever and malignancy, have been found accompanied by a decrease in T4 binding by TBPA (4, 10, 11) and an increase in the fractional rate of turnover of T4 (12, 13) . Since these states are usually associated with hypermetabolism, and since in the absence of known alterations of T4 binding, hypermetabolism per se may be accompanied by an increase in the fractional turnover of hormone (12, 14) , changes in T4-metabolism in these states cannot be ascribed to changes in hormonal binding. Similarly, salicylate and 2,4-dinitrophenol have been shown to decrease T4 binding by TBPA in vitro (5, 15, 16) and to accelerate the fractional turnover of T4 in man (17, 18) , but since both agents uncouple oxidative phosphorylation and induce a severe hypermetabolism (19, 20) , again the changes in T4 metabolism that these agents induce cannot necessarily be ascribed to an inhibition of T4-binding by TBPA.
Previous reports have indicated that certain congeners -of salicylate do not uncouple oxidative phosphorylations in vitro (19) or stimulate oxygen consumption in vivo (21, 22) . We therefore made a search among these compounds for inhibitors of T4 binding by TBPA in order to study their effects on T4-metabolism in man.
Methods and Materials
In vitro studies
The effect of benzoic acid and a number of its hydroxy-, dihydroxy-, and amino-substituted derivatives 2 on the binding of T4 in normal serum was assessed by electrophoretic and dialysis techniques.
Assessmnentt of T4 binding by filter paper electrophoresis.
By methods described in detail elsewhere (8) , electrophoretic studies of the binding of T4 were carried out in f resh serum from two normal donors. Samples of serum were enriched with a tracer amount of I"~-labeled T4, (2 Ac per ml, approximately 4 /Ag per 100 ml) and varying quantities of stable T4, sufficient to permit estimation of the T4-binding capacities of TBG and TBPA. Inhibitory effects of benzoic acid derivatives were tested in two ways. First, serum was enriched with derivatives to the desired molarity by adding to nine parts of serum one part of the derivative dissolved in isotonic saline solution; control sera were comparably diluted with saline alone. Second, derivatives were tested for inhibitory potency by adding them directly to the buffer in which electrophoresis was performed. The pH of the buffer was readjusted when necessary.
Electrophoresis of serum specimens was performed on Whatman 3 filter paper in Tris-maleate buffer, pH 8.6 (8) . In experiments with derivatives added directly to serum, control and experimental samples were subj ected to electrophoresis on the same filter paper sheet. In experiments in which buffer media were enriched with derivatives, duplicate samples of labeled serum were concurrently subj ected to electrophoresis in unenriched buffer. Electrophoresis was allowed to proceed for 15 hours at 120 v. Assessment of the distribution of labeled T4 among TBG, TBPA, and albumin and calculation of the T4-binding capacities of TBG and TBPA were carried out by methods described in detail elsewhere (8) . All experiments were performed at least twice and usually more often; results obtained with each derivative in separate experiments agreed closely.
Assessment of T4 binding by agar gel electrophoresis. Studies were conducted on glass slides in an agar gel4 (100 mg agar per 100 ml) prepared in 0.10 M phosphate buffer, pH 7.4.5 Sera were enriched only with tracer quantities of I'`-labeled T4. Samples of normal serum were diluted (9: 1) with benzoic acid derivatives dissolved in isotonic saline solution. Control specimens were comparably diluted with saline alone. Electrophoresis was allowed to proceed for 3 hours at a current of 10 ma.
Specimens were then dried under an infrared lamp, and radioautographs were prepared according to methods described previously (5 Thereafter, 1 ml of human serum was added to the incubation mixture to stop further hormonal degradation and to prevent the subsequent artifactual appearance of iodide during chromatography (23) . Tissues were then homogenized in their own serum-enriched incubation media, and samples of the homogenate were subjected to ascending filter paper chromatography in a butanol-dioxane-2 N ammonia (4: 1: 5) solvent system. Localization of the substrate T4 and the products of hormonal degradation and determination of their relative proportions were carried out with an automatic strip scanner and electronic integrator by methods described previously (24) . Values for the percentile degradation of T4 were corrected for the non-T4 radioactivity present in the tissue-free control samples.
In vivo studies
Studies of thyroxine turnover in vivo. Studies of the turnover and degradation of I"3-labeled T4 were carried out in eight patients: four of the patients had no endocrine or systemic disease; three had primary myxedema, one (A.S.) receiving treatment with 3 g of desiccated thyroid daily, and the other two (M.F. and B.P.) being untreated. The eighth patient, who had hypopituitarism, was studied twice before and once during replacement therapy with cortisone. In vivo metabolism of T4 was assessed by methods detailed elsewhere (25) . Briefly, each patient was given a single iv injection of 50 ,uc (approximately 1.5 ltg) of I"3-labeled T4 dissolved in 1% human serum albumin. In patients with normal thyroid function, thyroidal recycling of inorganic I"~liberated by the peripheral degradation of labeled hormone was prevented by the administration of 30 mg of methimazole every 6 hours. After injection of the labeled hormone, daily blood samples and, in patients R.G. and B.P., 24-hour urine collections were obtained for a total of from 14 to 21 days. After an initial control period of 6 to 8 days, gentisic acid, gamma-resorcylic acid, or, in the case of M.M., salicylamide was given in gelatin capsules in divided daily doses of from 4 to 12 g. The derivative was continued for from 6 to 9 days. In most instances, samples of blood were obtained for several days after the derivative had been discontinued. In two patients, A.S. and B.P., para-hydroxybenzoic acid was begun when gamma-resorcylic acid was stopped, and collection of blood samples was continued for an additional 6 to 7 days.
The fractional rate of hormonal turnover (k) during the control and experimental periods was determined from the declining concentration of the radioactivity in (4) . In two patients, R.G. and B.P., the clearance of T4 by degradative, rather than excretory, processes was calculated before, during, and after administration of the benzoic acid derivative (8) . This "degradative clearance" was calculated from the daily 24-hour urinary excretion of I"1 and the mean concentration of the radioactivity in serum during that same 24-hour period.
Either serum protein-bound iodine (PBI) or butanolextractable iodine (BEI)6 along with basal oxygen con- 6 Analyses for PBI and BEI were performed in the Boston Medical Laboratory by a modification of the method of Zak (26 As shown in Figure 5 , a decrease of the radioactivity in serum occurred during the first 24 hours after the derivative was begun, whereas an increase occurred when the derivative was discontinued. In one experiment (Patient A.S.), the concentration of the radioactivity in serum fell sharply during the first 48 hours of the experimental period and then for 3 days showed little change, after which an increase in the exponential rate of disappearance occurred. Although the TDS was increased during the administration of the derivative, the long time interval required to attain a steady state precluded calculation of the As a result of the changes in hormonal turnover and distribution, the daily clearance of T4 increased in all patients. Despite the lowering of the PBI that occurred during administration of the derivative, the daily rate of hormonal disposal, representing the product of daily clearance of T4 and PBJ, increased by an average of 15%, and this change was significant (p <0.01) for the group as a whole.
In one patient (A.S.), no change in the kinetics of peripheral T4 metabolism was induced by the administration of para-hydroxybenzoic acid. In one other patient (B.P.), para-hydroxybenzoic acid failed to prevent the fractional turnover rate and PBI from returning toward control values after gamma-resorcylic acid had been withdrawn.
In the two patients (R.G. and B.P.) in whom such measurements were made, the degradative clearance of labeled T4 increased significantly during the administration of gamma-resorcylic acid (Table IV) (Table V) . Discussion Increasing evidence indicates that a significant proportion of T4 in human serum is bound by TBPA (5, 9, 10). To date, however, it has not been satisfactorily demonstrated that TBPA plays a role in regulating the peripheral metabolism of T4 in vivo. Because of accompanying abnormalities, such as hypermetabolism, which follows the administration of salicylate (17) , or fever (12, 13) , which occurs in a variety of systemic disorders, it has not been possible to ascribe the acceleration of T4 turnover occurring in these states to the inhibition of T4 binding by TBPA commonly seen in these conditions.
We found certain derivatives of benzoic acid to be specific inhibitors of T4 binding by TBPA, both at pH 8.6 and 7.4. Indeed, two of the compounds, gentisic and gamma-resorcylic acids, proved to be more potent in this respect than salicylate itself. Both compounds have been used in the treatment of rheumatic fever and found to be free of serious side effects (29) (30) (31) (32) . In rats they are less toxic than salicylate (33). Since they also lack the calorigenic effects of salicylate (21, 22) , they appeared to be ideal agents for use in assessing the effects on peripheral T4 metabolism of inhibiting the binding of T4 by TBPA.7 The studies that were therefore carried out have provided what is apparently the first strong evidence that TBPA plays a significant role in regulating the peripheral metabolism of T4 in man.
One concept of the function of the extracellular T4-binding proteins, which appears to be true in the case of TBG, is that these proteins regulate the proportion of T4 present in the free or unbound state and thereby limit the quantity of hormone available to the cells for metabolic action and degradation (3, 4) . Within this concept, an inhibition of T4 binding and the consequent increase in the proportion of free T4 would permit a greater proportion of the total T4 to become affixed to the cell. This would be manifested in vivo by an expansion of the TDS and, if the fractional rate of degradation of cellular hormone were essentially unchanged, by an increase in the fractional turnover of hormone in the peripheral T4 pool. As a consequence, the total concentration of hormone in the peripheral pool would decrease until a new steady state is reached when total hormonal disposal once again equals hormonal supply. Presumably, this would occur when the total disposal of hormone has returned 7 In our studies, these compounds were well tolerated by the patients and did not change the state of hydration, as judged from serial measurements of the hematocrit. In three instances, mild dyspepsia occurred, but this was readily relieved by antacids. In the dosage employed (Table III) , maximal serum concentrations of 12 mg per 100 ml were attained with gentisic acid, whereas gammaresorcylic acid was present in concentrations exceeding 20 mg per 100 ml. In accord with previous studies in rats (21, 22) , the present experiments indicate that gammaresorcylic and gentisic acids do not induce hypermetabolism in man. Since hormonal disposal and degradative clearance were increased by the inhibitors of TBPA, the lack of calorigenic action may indicate that the increment of cellular hormone induced by the binding inhibitors was not available for the induction of metabolic action.
On the other hand, the normal individual can ingest relatively large quantities of thyroid hormone without developing hypermetabolism, and this tolerance to the hormone may explain the normal metabolic rates maintained by the patients in the present study (37) .
Finally, within the limitations of extrapolating findings in animal tissues to the human situation, no evidence could be obtained that these agents directly stimulate cellular mechanisms for the deiodination of T4. In view of all the foregoing evidence, the effects of these agents on the metabolism of T4 in man can be ascribed only to their effect on the binding of T4 by TBPA. The data would therefore suggest that TBPA plays an important role in regulating the peripheral metabolism of T4 in man.
Summary
Several noncalorigenic congeners of salicylate have been found to inhibit thyroxine binding by human serum prealbumin, both at pH 8.6 and 7.4, without interfering with the binding of thyroxine by other thyroxine-binding proteins. In man, these binding inhibitors lowered the proteinbound iodine in serum and increased both the fractional and total daily turnovers of thyroxine. The changes in thyroxine metabolism occurred without hypermetabolism or systemic side effects and did not depend upon a direct stimulation of the cellular mechanisms of thyroxine degradation. Thus, the effect of these agents on thyroxine metabolism could be ascribed only to their effect on the binding of thyroxine by prealbumin. The data therefore provide strong evidence that thyroxine-binding prealbumin plays an important role in regulating the metabolism of thyroxine in man.
carboxyl group (39) . Third, by invoking a charge separation in the anion, ortho-or para-substituents allow the phenyl group to participate in the resonance (38) . Owing to the greater number of forms contributing to the resonance hybrid, resonance stabilization of the anion is increased. All three effects, therefore, tend to increase the acidic dissociation constants of the ortho-hydroxyl substituted derivatives over that of the parent compound. Thus, gamma-resorcylic acid, which has two ortho-hydroxyl groups, has a dissociation constant 50 times greater than that of salicylic acid and 800 times greater than that of benzoic acid (39) . Thus, although it is not clear how this relationship is manifested, there appears to be a definite inverse correlation between the pK of the carboxyl group and the inhibitory potency of the compounds tested. Indeed, only the ortho-hydroxyl substituted derivatives were found to be competitive inhibitors of T4 binding by TBPA. The high concentrations of these derivatives that were necessary to inhibit T4 binding by TBPA and the reversal of inhibition that was achieved by relatively small concentrations of added T4 indicate, however, that their binding constants are, by several orders of magnitude, lower than that of T4.
